Business Context and Reporting Period
IRADIMED CORPORATION (IRMD) filed a Form 8-K on May 29, 2024, reporting the entry into a material definitive agreement. The filing concerns an amendment to the lease for the Company's manufacturing and headquarters facility in Winter Springs, Florida.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed is the monthly base rent under the amended lease, which is set at $34,133. This amount is subject to annual adjustments based on changes in the consumer price index. The Company remains responsible for insurance and maintenance expenses.
Material Changes
The primary material change is the extension of the lease term for the Company's principal facility. The lease term has been extended by one year, with a new expiration date of May 31, 2025. Additionally, the agreement includes a provision for a month-to-month tenancy that may continue for up to six months following the lease extension, potentially lasting until November 30, 2025, subject to termination notice.
Outlook, Risks, and Related Party Transactions
The lease amendment is a related party transaction, as the landlord, SUSI, LLC, is controlled by Roger Susi, the Company's President, Chief Executive Officer, and Chairman of the Board. The filing does not provide specific forward-looking guidance, risk factors, or commentary on unusual items beyond the terms of the lease extension.
Investor Verification Checklist
- Verify the total annual cost impact of the $34,133 monthly rent plus estimated insurance and maintenance expenses.
- Confirm the terms of the CPI adjustment mechanism for future rent increases.
- Review the full text of the Lease Amendment (Exhibit 10.1) for any additional covenants or termination rights.
- Assess the strategic necessity of the one-year extension versus potential long-term facility needs.